Intuitive Surgical Inc. ($ISRG) Stock Forecast: Down 4.7% Today

What is Intuitive Surgical Inc.?

Intuitive Surgical Inc. (ISRG) is a renowned medical technology company known for its da Vinci surgical systems. The company has shown impressive growth in recent years, with a strong focus on innovation and expanding its market presence in Europe.

Why is Intuitive Surgical Inc. going down?

ISRG stock is down 4.7% on Mar 13, 2026 15:40

• The bearish movement in ISRG stock today could be attributed to:
• Mixed short-term share performance contrasting with significant long-term gains, raising concerns about potential valuation risks.
• Underperforming the general market, including the S&P 500, Dow, and Nasdaq, despite analysts anticipating strong earnings and revenue growth.
• The stock trading at a premium valuation compared to industry peers, potentially leading to profit-taking by investors.
• The acquisition of distributors in Southern Europe could be a positive long-term strategic move for ISRG, enhancing its direct presence in key markets and further solidifying its position in the region.
• Analysts' suggestions of undervaluation and expectations of revenue growth over the next 12 months may indicate a potential rebound in the stock price following today's decline.

ISRG Price Chart

ISRG Technical Analysis

ISRG News

Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by First Trust Advisors LP

First Trust Advisors LP significantly increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 62.6% during the third quarter, now owning 406,057 shares worth approximately $39.997 million. Other institutional investors also adjusted their positions in the medical equipment provider, which has a consensus analyst rating of "Hold" and a target price of $106.20. Zimmer Biomet recently reported strong quarterly earnings, exceeding analyst expectations, and announced a quarterly dividend.

https://www.marketbeat.com/instant-alerts/filing-zimmer-biomet-holdings-inc-zbh-shares-acquired-by-first-trust-advisors-lp-2026-03-13/

Assessing Intuitive Surgical’s Valuation As Near Term Share Performance Contrasts With Longer Term Gains

Intuitive Surgical (ISRG) has seen mixed share performance recently, with negative short-term returns contrasting with significant long-term gains. Despite a recent dip, analysts suggest the stock is undervalued with a fair value of $532.46 against its current trading price of $479.27, driven by its robust recurring revenue model from its large installed base of da Vinci systems. However, its high P/E ratio of 59.6x compared to the industry average raises questions about potential valuation risk if expectations cool.

https://simplywall.st/stocks/us/healthcare/nasdaq-isrg/intuitive-surgical/news/assessing-intuitive-surgicals-valuation-as-near-term-share-p

Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights

Intuitive Surgical, Inc. (ISRG) stock fell 2.76% in its latest trading session, underperforming the S&P 500, Dow, and Nasdaq. Analysts anticipate strong earnings and revenue growth for the company's upcoming financial report, with full-year estimates also showing significant increases. Intuitive Surgical currently holds a Zacks Rank #1 (Strong Buy) and trades at a premium valuation compared to its industry peers.

https://sg.finance.yahoo.com/news/intuitive-surgical-inc-isrg-suffers-220004661.html

Intuitive Surgical Stock Performance & Growth Analysis | 2026 Update - News and Statistics

Intuitive Surgical (ISRG) has significantly outperformed the S&P 500 over the past six months, with a 9.4% gain and shares trading at $491.85. The company, known for its da Vinci surgical systems, has shown impressive growth with a 18.2% compounded annual revenue growth rate and 21.4% EPS growth rate over the last five years. Analysts anticipate a 14.2% revenue increase over the next 12 months, and the stock currently trades at 48.5x forward P/E.

https://www.indexbox.io/blog/intuitive-surgical-stock-outperforms-sp-500-gains-94-in-six-months/

Intuituve (ISRG) Boosting Southern Europe Presence with Purchase of Distributors

Intuitive Surgical Inc. (ISRG) has expanded its direct presence in Southern Europe by acquiring the distribution businesses for its da Vinci and Ion systems from ab medica, Abex, and Excelencia Robótica. This move allows Intuitive to operate directly in Italy, Spain, Portugal, Malta, San Marino, and associated territories, integrating approximately 250 new employees into its European commercial and marketing organization. As of late 2025, over 470 da Vinci systems were installed in Italy, Spain, and Portugal, with the Ion system recently launched in Italy and Spain.

https://www.insidermonkey.com/blog/intuituve-isrg-boosting-southern-europe-presence-with-purchase-of-distributors-1714873/

Trending Today

Cleveland-Cliffs Inc. ($CLF) Stock Forecast: Down 5.3% Today

Insulet Corporation ($PODD) Stock Forecast: Down 7.1% Today

KKR & Co. Inc. Class A ($KKR) Stock Forecast: Up 5.1% Today

Adobe Inc. ($ADBE) Stock Forecast: Down 6.2% Today

FuelCell Energy ($FCEL) Stock Forecast: Down 5.0% Today

Plug Power Inc. ($PLUG) Stock Forecast: Down 5.1% Today

DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Down 6.0% Today

Ulta Beauty Inc. ($ULTA) Stock Forecast: Down 14.0% Today

SNDL Inc. ($SNDL) Stock Forecast: Down 5.6% Today

Amplitude Inc. ($AMPL) Stock Forecast: Down 5.3% Today

Intuitive Surgical Inc. Price History

09.05.2025 - ISRG Stock was up 2.5%

• ISRG's shares have been on a recovery path, gaining 12.7% quarter-to-date after a significant decline from its all-time high. Investors are now eyeing the stock for a potential buying opportunity.
• The company's latest innovation, the da Vinci 5 surgical system, is garnering attention for its precision, power, and potential, with strong placements in Q1 driving adoption rates.
• ISRG outpaced the stock market gains, closing the day with a 1.11% increase, showcasing resilience and investor confidence in the company's future prospects.
• The options market sentiment towards ISRG is notably bullish, indicating a positive outlook from deep-pocketed investors. This optimism could be contributing to the stock's upward momentum as market players take note of this significant move.

13.02.2026 - ISRG Stock was down 4.7%

• The bearish movement in ISRG stock today could be attributed to:
• Mixed short-term share performance contrasting with significant long-term gains, raising concerns about potential valuation risks.
• Underperforming the general market, including the S&P 500, Dow, and Nasdaq, despite analysts anticipating strong earnings and revenue growth.
• The stock trading at a premium valuation compared to industry peers, potentially leading to profit-taking by investors.
• The acquisition of distributors in Southern Europe could be a positive long-term strategic move for ISRG, enhancing its direct presence in key markets and further solidifying its position in the region.
• Analysts' suggestions of undervaluation and expectations of revenue growth over the next 12 months may indicate a potential rebound in the stock price following today's decline.

04.01.2026 - ISRG Stock was down 5.1%

• Machina Capital S.A.S. and other significant institutional investors have notably increased their holdings in ISRG, signaling confidence in the company's future.
• Despite positive Q3 performance and strategic growth positioning, ISRG witnessed a bearish movement, potentially attributed to profit-taking or shifts in market sentiment.
• The upcoming earnings release from Zimmer Biomet Holdings (ZBH) might have impacted market dynamics, leading to a more cautious approach towards medical equipment stocks like ISRG.
• Market sentiments surrounding healthcare and medical technology sectors likely influenced ISRG's bearish movement, despite its favorable long-term growth prospects.

10.11.2025 - ISRG Stock was down 2.8%

• An institutional investor increased its stake in ISRG by 1.2% in Q2, despite recent insider selling by executives, following the company's strong Q3 earnings.
• Another institutional investor, Daiwa Securities Group Inc., sold 6,055 shares of ISRG, reducing its holdings, while other institutional investors also adjusted their positions in the company.
• The market movement could be attributed to profit-taking by institutional investors after a period of significant growth, despite positive earnings and analyst consensus ratings.
• The bearish trend might also be influenced by overall market conditions and investor sentiment towards the healthcare sector, as highlighted by the positive performance of other surgical equipment companies in Q3.

06.00.2026 - ISRG Stock was up 3.7%

• Despite significant insider selling and reduced stakes by asset management firms, major institutional investors increasing their positions in ISRG have likely instilled confidence in the market.
• The utilization of AI in driving growth and innovation within the medical sector has positioned companies like Intuitive Surgical for strong performance, attracting investors and contributing to the bullish movement.
• While the stock may be trading at a premium valuation with a high P/E ratio, the perceived undervaluation and potential for future growth due to product innovation and AI integration have likely fueled investor optimism, leading to the bullish market movement.

06.00.2026 - ISRG Stock was up 5.0%

• Noteworthy insider selling by Greenleaf Trust and Hennion & Walsh Asset Management Inc. did not deter overall market optimism towards ISRG today.
• Discussions around the utilization of Artificial Intelligence (AI) in the medical sector, including within companies like ISRG, likely influenced investor sentiment positively, reflecting interest in the company's growth prospects.
• ISRG's strong earnings report, surpassing revenue and EPS projections, is seen as a key factor reinforcing investor trust in the company's future performance.
• Variations in institutional investors' behavior, with some increasing stakes and others decreasing positions in ISRG, suggest diverse views on the company's long-term outlook. Nevertheless, the prevailing market sentiment remained favorable, supporting the bullish trend in ISRG.

14.00.2026 - ISRG Stock was down 5.5%

• Despite strong Q4 revenue and procedure growth, ISRG's stock saw a 6% decline in pre-market trading.
• Concerns regarding a slowdown in Ion endoluminal system placements, despite an increase in da Vinci system placements, appear to have fueled the bearish movement.
• Investor sentiment may have been influenced by the company's anticipation of a potential deceleration in da Vinci procedures growth for 2026.
• Watching for the stock's current undervaluation in comparison to estimated fair value, as well as expected advancements in AI-enabled surgery, could be crucial for potential future market movements.

02.00.2026 - ISRG Stock was down 1.2%

• The downturn in ISRG stock today may be linked to investors seizing profits following a recent rise in the stock price.
• Despite notable developments like a robust Q3 performance and increased interest from institutional investors, market sentiment could be swayed by overall uncertainty and volatility in the healthcare domain.
• The forthcoming Q4 earnings call set for January 22 might influence the stock's trajectory, as investors await insights on future growth prospects.
• The market's perception of ISRG could also be influenced by broader economic conditions and industry trends impacting healthcare and technology sectors.

22.09.2025 - ISRG Stock was up 16.5%

• ISRG exceeded Q3 earnings and revenue expectations, demonstrating robust financial performance.
• The introduction of the new da Vinci 5 system is stimulating hospital upgrades and premium pricing, potentially influencing the strong performance in Q3.
• Investors responded favorably to ISRG's solid Q3 results, resulting in a notable increase in the stock price.
• The company's consistent track record of impressive earnings and positive future prospects are likely driving the current bullish trend in ISRG's stock.

22.09.2025 - ISRG Stock was up 13.4%

• Third-quarter results revealed that Intuitive Surgical achieved $2.51 billion in revenue, a 23% increase from the previous year, surpassing predictions. The surge in da Vinci placements and global procedure growth fueled this remarkable performance.
• Despite a slight gross margin dip, the company's adjusted earnings of $2.40 per share exceeded forecasts, propelling ISRG stock by 17%.
• Investor optimism was evident as the market responded favorably to the earnings and revenue beat, showcasing confidence in Intuitive Surgical's financial prowess and industry prominence.
• With a track record of surpassing earnings estimates and a bright outlook, Intuitive Surgical is positioned to potentially surpass expectations in the future, contributing to the bullish trend in its stock value.

01.09.2025 - ISRG Stock was down 2.1%

• The bearish movement in ISRG stock may be linked to profit-taking by investors following a recent positive trend.
• Concerns over the national security review affecting the medical supply chain may have contributed to uncertainty in the healthcare sector, prompting a sell-off in ISRG shares.
• There might be worries among investors about potential disruptions in the supply chain of medical devices, including robotic surgery systems, which could impact ISRG's operations and revenue.
• The market's response to the national security review may have sparked a broader sell-off in healthcare stocks, including ISRG, as investors reevaluate the risks associated with the sector.

23.06.2025 - ISRG Stock was down 2.8%

• Despite exceeding Q2 earnings and revenue estimates, ISRG's stock took a bearish turn.
• Concerns rose among investors due to a decrease in gross margin outlook impacted by tariffs, overshadowing the positive earnings results.
• The FDA's approval for ISRG's Vessel Sealer Curved, adding to the da Vinci system's capabilities, may have been overshadowed by the margin outlook news.
• Comparisons with rival Stryker in the robotic surgery sector potentially affected investor sentiment, contributing to the bearish trend in ISRG's stock.